The primary objective of the research is to study the relation between the presence and /or the anti SARS-Co-V-2 IgM level in an early stage of COVID-19 infection, and the evolution of the illness.
The secondary objective is to determinate in what manner response of IgM anti-SARS-Co-V-2 relates to patient's immunity statute, in regards to the other so-called humain "seasonal coronavirus".
Study Type
OBSERVATIONAL
Enrollment
500
Hospitalization
Absence of hospitalization versus hospitalization without ventilation during SARS-CoV-2 infection
Time frame: through study completion, an average of 1 month
Ventilation
Non ventilation versus ventilation during Covid-19 hospitalization
Time frame: through study completion, an average of 1 month
Hospitalization at Ambroise Paré hospital
Hospitalization at Ambroise Paré hospital during SARS-CoV-2 infection
Time frame: through study completion, an average of 1 month
Oxygenotherapy
Use of high-flow oxygenotherapy
Time frame: through study completion, an average of 1 month
Ventilation
Ventilation during SARS-CoV-2 infection
Time frame: through study completion, an average of 1 month
Thoracic CT
Thoracic CT result during SARS-CoV-2 infection
Time frame: through study completion, an average of 1 month
Patient's vital statute
Death of hospitalized patients in Ambroise Paré hospital
Time frame: through study completion, an average of 1 month
IgM anti-SARS-Co-V-2 presence
IgM anti-SARS-Co-V-2 level
Time frame: through study completion, an average of 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.